Skip to main content

Table 1 Clinical-pathological characteristics of the study participants (N: 235)

From: Observational study of coagulation activation in early breast cancer: development of a prognostic model based on data from the real world setting

Characteristics Number (N) and percentage (%)
Age (years) N (%)
Mean (SD) 60.3 (13.4)
Histology
 Intraductal carcinoma 204 (86.8)
 Lobular carcinoma 14 (6.0)
 Other 9 (3.8)
 Unknown 8 (3.4)
pT stage
 pT1 131 (55.7)
 pT2 104 (44.3)
pN stage
 pN0 141 (60.0)
 pN1 83 (35.3)
 Unknown 11 (4.7)
Grading
 1 16 (6.8)
 2 126 (53.6)
 3 64 (27.2)
 Unknown 29 (12.3)
Estrogen receptor status
 Positive 186 (79.1)
 Negative 49 (20.9)
Progesterone receptor status
 Negative 71 (30.2)
 Positive 164 (69.8)
HER2 status
 Positive 39 (16.6)
 Negative 196 (83.4)
% Ki-67
 ≤ 15 142 (60.4)
 > 15 89 (37.9)
 Unknown 4 (1.7)
Molecular subtype
 Triple-negative 30 (12.8)
 Luminal A 118 (50.2)
 Luminal B 69 (29.3)
 HER2-enriched 18 (7.7)